key: cord-1013487-u4ewxm11
authors: Abbas, Ahmed M.; Ahmed, Omar A.; Shaltout, Asmaa S.
title: Hydatidiform mole in the era of COVID‐19 pandemic. Is there an association?
date: 2020-05-05
journal: Am J Reprod Immunol
DOI: 10.1111/aji.13253
sha: 4ea5055bab4f3bc30556257b5eaf738802c823df
doc_id: 1013487
cord_uid: u4ewxm11

Coronavirus disease 2019 (COVID‐19) is considered a worldwide pandemic. COVID‐19 patients had profound immune dysregulation so they could be susceptible for adverse pregnancy outcomes as hydatidiform mole. In this article, we tried to explain the link between hydatidiform mole and COVID‐19.

ity that variable viral, bacterial, and parasitic infections can mediate HM.

In HM, there is a Lower white blood cell levels compared to healthy pregnancy that reflects the association of HM with a poorer inflammatory function enhancing trophoblastic invasion. 4 Additionally, in patients with GTDs, there was a significant decrease in the percentage and absolute counts of lymphocytes. 5 Previous studies showed that activation of endometrial lymphocytes and macrophages can produce a negative environment affect the implanting embryo. One of the causative factors for activation is the non-reproductive tissue-specific antigens such as those of infectious organisms. 7 This activation will lead to release of variable cytokines including interleukin 1 (IL-l), interleukin-2 (IL-2), interleukin-6 (IL-6), interferon tl and y (IFNU, y), and tumor necrosis factor-a (TNFa). Therefore, these cytokines may be used as valuable biomarkers in the diagnosis of GTDs as they have a definite role in its pathogenesis.

COVID-19 is characterized by increased IL-2, IL-7, granulocyte colony-stimulating factor, interferon-γ inducible protein 10, and TNF-α. 6 This increases the interest that raised cytokines levels in COVID-19 patients may affect the normal implantation leading to development of HM.

Despite the fact that HM is multifactorial in its etiology, we still have limited knowledge about its immunological aspects. Further studies are recommended to show the COVID-19 contribution to the pathogenesis of HM. Till that, we suggest that obstetricians advise pregnant women with HM that they could have COVID-19 disease, and those patients could be referred to perform COVID-19 testing through nasopharyngeal swab.

WHO declares COVID-19 a pandemic

Textbook of Autoinflammation

A novel mutation in NLRP7 related to recurrent hydatidiform mole and reproductive failure

Complete blood count parameters may have a role in diagnosis of gestational trophoblastic disease

The potential value of red blood cell distribution width in patients with invasive hydatidiform mole

COVID-19: consider cytokine storm syndromes and immunosuppression

Serum cytokines in gestational trophoblastic diseases

Hydatidiform mole in the era of COVID-19 pandemic. Is there an association?

The authors state that there are no conflicts of interest.

https://orcid.org/0000-0002-2359-2729